Skip to main content

News & Events

News & Announcements

Paragon Bioservices Announces Promotion of Peter Buzy to President and CEO and election to Paragon’s Board of Directors

Appointment Consolidates CDMO’s Leadership for Sustaining Strong Performance

Baltimore, MD, September 12, 2016/PR Newswire/ – Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today the promotion of Mr. Peter Buzy to President and Chief Executive Officer and his election to Paragon’s Board of Directors.  Mr. Buzy initially joined Paragon as Chief Operation Officer in October 2014 and later was assigned the responsibility of President. He has played a critical role in leading efforts to strengthen the management team and operations following a private equity financing led by NewSpring Capital and Camden Partners.

“Pete’s appointment to President and Chief Executive Officer reflects his impressive leadership and extensive corporate operations experience, as well as his in-depth financial and commercial expertise. In Pete’s tenure at Paragon, he has proven himself to be a tremendous asset to the company. The Board looks forward to continuing to work closely with him to build on his successful leadership in strengthening and growing the business,” stated Dr. Kapila Ratnam, Board Director and Partner at New Spring Capital.

Click here to read more